Morimoto M, Maishi N, Hida K: Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression, Cancer Drug Resistance, 2023, doi: 10.20517/cdr.2023.121.
Yu Li, Maishi N, Matsuda A, Hida K*: The functional network of biglycan: a new frontier in tumor progression, Proteoglycan Res, 2023(IF=0) doi: 10.1002/pgr2.11
Haruhisa Watanabe , Nako Maishi, Marie Hoshi-Numahata, Mai Nishiura, Atsuko Nakanishi-Kimura, Kyoko Hida and Tadahiro Iimura*: Skeletal-Vascular Interactions in Bone Development, Homeostasis, and Pathological Destruction, Int. J. Mol. Sci. 2023, 24, 10192(IF= 6.132) doi:10.3390/ijms241310912
Hida K, Maishi N, Matsuda A, Yu L: Beyond starving cancer, antiangiogenic therapy, J Med Ultrasonic, 2023(IF= 1.457 ) doi:10.1007/s10396-023-01310-1
英語論文
Tsumita T §,Takeda R §, Maishi N, Hida Y, Sasaki M, Orba Y, Sato A, Toba S, Ito W, Teshirogi T, Sakurai Y, Iba T, Naito H, Ando H, Watanabe H, Mizuno A, Nakanishi T, Matsuda A, Zixiao R, Lee JW,Iimura T, Sawa H*, Hida K*: Viral uptake and pathophysiology of the lung endothelial cells in age-associated severe SARS-CoV-2 infection models, Aging Cell,2023, 23(2), e14050, doi: 10.1111/acel.14050
Kikuchi H, Maishi N, YU L, Jia Z, Li C, Sato M, Takeda R, Ishizuka K, Hida Y, Shinohara N and *Hida K,: Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer, Brit J Cancer, doi:10.1038/s41416-023-02498-2
北海道大学プレスリリース:「シスプラチンの低用量維持投与は抗腫瘍効果を増強する~抗がん剤による炎症性変化を抑え、腫瘍血管を正常化する新たな治療法を提案~」
Yu Li, Hong Y, Maishi N, Yanagawa Matsuda A, Hida Y, Hasebe A,Kitagawa Y, Hida K*: Oral bacterium Streptococcus mutans promotes tumor metastasis via thrombosis formation, Cancer Sci, 115(2), 648-659,2024, doi: 10.1111/cas.16010
北海道大学プレスリリース:「口腔内細菌による血栓症はがんの転移を促進する~がん患者の口腔清掃の重要性を明らかに~」
Morimoto M, Maishi N, Tsumita T, Alam MT, Kikuchi H, Hida Y, Yoshioka Y, Ochiya T, Annan DA, Takeda R, Kitagawa Y, Hida K: miR-1246 in tumor extracellular vesicles promotes metastasis via increased tumor cell adhesion and endothelial cell barrier destruction, Front.Oncol, 13 , doi:10.3389/fonc.2023.973871/
Sato M, Maishi N, Hida Y, Yanagawa-Matsuda A, Alam MT, Sakakibara-Konishi J, Nam JM, Onodera Y, Konno S, Hida K: Angiogenic inhibitor pre-administration improves the therapeutic effects of immunotherapy, Cancer Med, 2023,12(8), 9760-9773 北海道大学プレスリリース「血管新生阻害剤の先行投与は抗腫瘍効果を増強する~腫瘍血管正常化を活かした新たな治療スケジュールを提案~」
Hida K: The 1st International Symposium on Cancer Immunology and Immunotherapy, “Contribution of tumor endothelial cells in tumor progression”, 2024.3.23, Sapporo
Yu Li, Maishi N, Akahori E, Hong Y, Hasebe A, Takeda R, Matsuda A, Hida Y, Kitagawa Y, Hida K: The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation and thrombosis, Vascular Biology 2023,10.18, Newport, USA
Li Yu, Maishi N, Akahori E, Hasebe A, Takeda R, Yanagawa Matsuda A, Hida Y, Nam JM, Onodera Y, Kitagawa Y, Hida K: 第82回日本癌学会学術総会 [YSA]Cancer Science ヤングサイエンティストアワード受賞講演 “The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation” , 9.21, 横浜
Yu L, Maishi N, Akahori E, Hasebe A, Takeda R, Matsuda A, Hida Y, Kitagawa Y, Hida K, 2023 KVBM Annual Meeting & AAVBM in partnership with ICoLA, Korea-Japan young investigator session, The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation and thrombosis, 2023.9.14, Seoul, Korea
Hida K: The 2023 Conference of Asia Pacific Societies for Extracellular Vesicles(APSEV), “Vasclar endothelial cell heterogeneity in diseases”, 2023.4.1, Taipei
Hida K; Analysis of lung endotheliopathy in lethal mice infected with mouse-adapted SARS-CoV-2, Poster, 2023 KVBM Annual Meeting & AAVBM in partnership with ICoLA, Seoul, 2023.9.14-16, Seoul, Korea
Yu L, Hong Y, Maishi N, Matsuda A, Hida Y, Hasebe A, Kitagawa Y, Hida K: Oral bacterium streptococcus mutans promotes tumor metastasis via thrombosis formation, Oral, 第31回 日本血管生物医学会学術集会, 2023.12.9-10(神戸)
Ren Zixiao, Matsuda A, Maishi N, Niiyama T, Ohiro Y, Hida K: The mechanism of neogenesis and development of Tumor-associated HEV, Oral, 第127回北海道癌談話会, 2023.11.11(札幌)
Hong Y, Yu L, Takahashi I, Maishi N, Sakurai Y, Hida Y, Yoshioka Y, Ochiya T, Kitagawa Y, Hida K: Comparison miRNA in extracellular vesicles secreted from tumor endothelial cells between high and low metastatic tumors, ポスター, 第10回 日本細胞外小胞学会学術集会, 2023.10.24(札幌)
Ren Zixiao, Aya Matsuda, Nako Maishi, Takashi Niiyama, Yoichi Ohiro, Kyoko Hida: The mechanism of neogenesis and development of Tumor-associated HEV, Poster, 第9回 北大・部局横断シンポジウム, 2023.10.11(札幌)
Yuying Hong, Li Yu, Ikuko Takahashi, Nako Maishi, Yuya Sakurai, Yasuhiro Hida, Yusuke Yoshioka, Takahiro Ochiya, Yoshimasa Kitagawa, Kyoko Hida, Effects of miRNA in extracellular vesicles derived from tumor endothelial cells promote tumor microenvironment formation and metastasis, Poster, 第9回 北大・部局横断シンポジウム, 2023.10.11(札幌)
Zi Jia, Maishi N , Takekawa H, Matsuda A , Nakade T, Nakamura T, Harashima H, Hida Y, Hida K: Targeting tumor endothelial cells by EGCG causes antiinflammatory and anti-thrombotic effects, Poster, The 82nd annual meeting of the Japanese Cancer Association. 2023. 9. 22, Yokohama
Li Yu, Maishi N, Yuying Hong, Matsuda A, Hida Y, Hasebe A, Nam JM, Hida K: “The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing thrombosis”, Poster, The 82nd annual meeting of the Japanese Cancer Association. 2023. 9. 21, Yokohama
Yu Li, Maishi N, Akahori E, Hasebe A, Takeda R, Matsuda A, Hida Y,Kitagawa Y, Hida K: 口腔常在菌 Streptococcus mutans が引き起こす血管炎症は転移を促進する, ポスター, 第32回日本がん転移学会学術集会・総会, 2023.7.20(仙台)